BTLA/CD272 Rekombinanter Antikörper
BTLA/CD272 Rekombinant Antikörper für WB, IF/ICC, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
Maus
Anwendung
WB, IF/ICC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
242133E5
Kat-Nr. : 84754-5-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
84754-5-PBS bindet in WB, IF/ICC, Indirect ELISA BTLA/CD272 und zeigt Reaktivität mit Maus
Getestete Reaktivität | Maus |
Wirt / Isotyp | Kaninchen / IgG |
Klonalität | Rekombinant |
Typ | Antikörper |
Immunogen | BTLA/CD272 fusion protein Eg1843 |
Vollständiger Name | B and T lymphocyte associated |
Berechnetes Molekulargewicht | 34kDa |
Beobachtetes Molekulargewicht | 50 kDa |
GenBank-Zugangsnummer | AAI08964.1 |
Gene symbol | Btla |
Gene ID (NCBI) | 208154 |
Konjugation | Unkonjugiert |
Form | Liquid |
Reinigungsmethode | Protein A purfication |
Lagerungspuffer | PBS only |
Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
BTLA, or B and T lymphocyte attenuator, is a member of the CD28 superfamily and is a type I membrane glycoprotein identified as an inhibitory receptor (PMID: 33859648). BTLA is extensively expressed in lymph nodes, thymus, and spleen, with little or no expression in organs such as the heart, kidney, brain, and liver (PMID: 33859648). Among immune cells, BTLA is primarily expressed in B and T cells, with higher expression in B cells compared to T cells in the mouse spleen (PMID: 33859648). BTLA plays a crucial role in regulating stimulatory and inhibitory signals in immune responses.